Disease Info Card

Malignant Carcinoid Syndrome

Information about Malignant Carcinoid Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Malignant Carcinoid Syndrome

Most recent studies have shown that Malignant Carcinoid Syndrome shares some biological mechanisms with bronchial-neoplasms, carcinoid-heart-disease, carcinoid-tumor, carcinoma, diarrhea, flushing, gastrointestinal-neoplasms, heart-diseases, ileal-neoplasms, intestinal-neoplasms, liver-neoplasms, lung-neoplasms, malignant-neoplasms, malignant-paraganglionic-neoplasm, metastatic-malignant-neoplasm-to-the-liver, neoplasm-metastasis, neoplasms, neuroendocrine-tumors, pain, pancreatic-neoplasm.

Among the many pathways, these few ones have gauged particular interests from scientists studying Malignant Carcinoid Syndrome, and have been seen in publications frequently: Acid Secretion, Anaphylaxis, Cell Growth, Cell Proliferation, Coagulation, Cortisol Secretion, Excretion, Gastric Acid Secretion, Gastric Emptying, Growth Hormone Secretion, Hormone Secretion, Insulin Secretion, Localization, Menopause, Pathogenesis, Secretion, Serotonin Secretion, Transport, Vasodilation

Quite a number of genes have been found to play important roles in Malignant Carcinoid Syndrome, such as CALCA, ENO2, GAST, GCG, GNA12, GNAI1, INS, KNG1, MTOR, POMC, PPY, PTPRF, RAI1, SMS, SST, SYP, TAC1, VIP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.